{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:03:29Z","timestamp":1769238209606,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Heath Research","doi-asserted-by":"crossref","award":["381280"],"award-info":[{"award-number":["381280"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["OGI-150"],"award-info":[{"award-number":["OGI-150"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reumafonds","award":["848006001"],"award-info":[{"award-number":["848006001"]}]},{"name":"Arthritis Society of Canada","award":["GC-18-001"],"award-info":[{"award-number":["GC-18-001"]}]},{"DOI":"10.13039\/501100010787","name":"Genome Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013061","name":"Ontario Genomics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10067-023-06616-6","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:24:22Z","timestamp":1684466662000},"page":"2173-2180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-9893","authenticated-orcid":false,"given":"Gillian R.","family":"Currie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherina G.M.","family":"Groothuis-Oudshoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinka","family":"Twilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M. A.","family":"Kip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan J.","family":"Vastert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"issue":"6","key":"6616_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40272-019-00362-6","volume":"21","author":"O Halyabar","year":"2019","unstructured":"Halyabar O, Mehta J, Ringold S, Rumsey DG, Horton DB (2019) Treatment withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature. Pediatr Drugs 21(6):469\u2013492","journal-title":"Pediatr. Drugs"},{"issue":"6","key":"6616_CR2","first-page":"819","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM et al (2018) Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis 77(6):819\u2013828","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"6616_CR3","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","volume":"75","author":"J Guzman","year":"2016","unstructured":"Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N et al (2016) The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis 75(6):1092\u20131098","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"6616_CR4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/acr.23435","volume":"70","author":"G Simonini","year":"2018","unstructured":"Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A et al (2018) Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: clinical and laboratory correlates of remission duration. Arthritis Care Res 70(7):1046\u20131051","journal-title":"Arthritis Care Res."},{"key":"6616_CR5","doi-asserted-by":"crossref","unstructured":"Currie GR, Pham T, Twilt M, MJ IJ, Hull PM, MMA K et al (2022) Perspectives of pediatric rheumatologists on initiating and tapering biologics in patients with juvenile idiopathic arthritis: a formative qualitative study. Patient 15(5):599\u2013609","DOI":"10.1007\/s40271-022-00575-x"},{"issue":"3","key":"6616_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/acr.24129","volume":"73","author":"DB Horton","year":"2021","unstructured":"Horton DB, Salas J, Wec A, Kohlheim M, Kapadia P, Beukelman T et al (2021) Making decisions about stopping medicines for well-controlled juvenile idiopathic arthritis: a mixed-methods study of patients and caregivers. Arthritis Care Res 73(3):374\u2013385","journal-title":"Arthritis Care Res."},{"issue":"1","key":"6616_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/11595980-000000000-00000","volume":"14","author":"T Broughton","year":"2012","unstructured":"Broughton T, Armon K (2012) Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus. Paediatr Drugs 14(1):7\u201312","journal-title":"Paediatr. Drugs"},{"issue":"5","key":"6616_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10067-015-2876-3","volume":"34","author":"S Meyfroidt","year":"2015","unstructured":"Meyfroidt S, Hulscher M, De Cock D, Van der Elst K, Joly J, Westhovens R et al (2015) A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis. Clin Rheumatol 34(5):861\u2013869","journal-title":"Clin Rheumatol."},{"key":"6616_CR9","doi-asserted-by":"publisher","unstructured":"Holyer J, Taylor WJ, Gaffo A, Hosie G, Horne A, Mihov B, et al. Which attributes are most and least important to patients when considering gout flare burden over time? a best-worst scaling choice study. J Rheumatol 2021 https:\/\/doi.org\/10.3899\/jrheum.210605","DOI":"10.3899\/jrheum.210605"},{"issue":"1","key":"6616_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13561-015-0079-x","volume":"6","author":"AC M\u00fchlbacher","year":"2016","unstructured":"M\u00fchlbacher AC, Kaczynski A, Zweifel P, Johnson FR (2016) Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Heal Econ Rev 6(1):2","journal-title":"Heal. Econ. Rev."},{"issue":"1","key":"6616_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40271-019-00401-x","volume":"13","author":"IL Hollin","year":"2020","unstructured":"Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, DiSantostefano R et al (2020) Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and reviewers. Patient 13(1):121\u2013136","journal-title":"Patient."},{"issue":"7","key":"6616_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63(7):929\u2013936","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"3","key":"6616_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/002224379303000303","volume":"30","author":"J Swait","year":"1993","unstructured":"Swait J, Louviere J (1993) The role of the scale parameter in the estimation and comparison of multinomial logit models. J Market Res 30(3):305\u2013314","journal-title":"J. Market. Res."},{"key":"6616_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/PPA.S180994","volume":"13","author":"J Veldwijk","year":"2019","unstructured":"Veldwijk J, Groothuis-Oudshoorn CGM, Kihlbom U, Langenski\u00f6ld S, Dekker E, Kallenberg FGJ et al (2019) How psychological distance of a study sample in discrete choice experiments affects preference measurement: a colorectal cancer screening case study. Patient Prefer Adherence 13:273\u2013282","journal-title":"Patient Prefer Adherence."},{"issue":"3","key":"6616_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3899\/jrheum.161078","volume":"44","author":"DB Horton","year":"2017","unstructured":"Horton DB, Onel KB, Beukelman T, Ringold S (2017) Attitudes and approaches for withdrawing drugs for children with clinically inactive nonsystemic JIA: a survey of the childhood arthritis and rheumatology research alliance. J Rheumatol 44(3):352\u2013360","journal-title":"J Rheumatol."},{"issue":"1","key":"6616_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12969-019-0342-5","volume":"17","author":"S Shenoi","year":"2019","unstructured":"Shenoi S, Nanda K, Schulert GS, Bohnsack JF, Cooper AM, Edghill B et al (2019) Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey. Pediatr Rheumatol 17(1):48","journal-title":"Pediatr. Rheumatol."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06616-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06616-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06616-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:11:37Z","timestamp":1689232297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06616-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6616"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06616-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DM reports grants from Canadian Institutes of Health Research, Alberta innovates, and the Arthritis Society supports for attending meetings from Illumina and ISPOR, and consulting fees from Analytica. All are outside of the submitted work.RY reports consulting fees from Novartis and Lily, outside the submitted work.SV reports grants and personal fees from SOBI and Novartis during the conduct of the study, outside the submitted work.JS reports consulting fees from Amgen, outside the submitted work.NW reports honoraria from UBC for a lecture on vaccinations.All other authors declare that they gave no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"There was no direct patient involvement in this component of the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient involvement"}}]}}